25 results on '"Cipolli, M"'
Search Results
2. EPS5.09 Changes in nutritional status and muscular strength in adult patients with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ETI)
3. Gluten sensitivity and ‘normal’ histology: is the intestinal mucosa really normal?
4. P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
5. P183 Increase of HLA-G in plasma of cystic fibrosis paediatric patients treated with Docosahexaenoic acid (DHA)
6. P031 What is the role of sweat ions ratio in the diagnosis of cystic fibrosis?
7. P007 Functional characterisation of c.1584+18672bpA>G/2183AA>G CFTR variant in rectal organoids
8. WS21.5 Response to ivacaftor of the rare CFTR variants W57G and A234D in intestinal organoids and Fisher Rat Tyroid (FRT) cells
9. WS06.4 Early Pseudomonas aeruginosa (Pa) isolation impacts on N2-Multiple Breath Washout (MBW) and body mass index (BMI) percentile in children with cystic fibrosis
10. WS04.2 Electronic nose (E-nose) analysis of systemic volatile organic compounds (VOCs) pattern distinguishes paediatric patients with cystic fibrosis (CF) from healthy controls (HC) and depicts disease status
11. P105 The growth in children with Celiac disease after the gluten free diet: a comparison between Italian and American children
12. IPD2.07 Retrospective observational study in cystic fibrosis patients homozygous for F508del treated with lumacaftor/ivacaftor in a compassionate use programme
13. 291 Colon cancer screening program in adult CF patients: an Italian cross-sectional pilot study
14. 111 Non-tuberculous mycobacteria in patients with cystic fibrosis: detection and isolation from respiratory samples. Results of a cross-sectional study
15. 112 Analysis of long-term use of liposomal amikacin for inhalation (LAI) in patients with cystic fibrosis (CF) who have chronic infection from Pseudomonas aeruginosa
16. WS7.3 Once-daily liposomal amikacin for inhalation is noninferior to twice-daily tobramycin inhalation solution in improving pulmonary function in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa
17. 353 Clinical trial drop out(s): Experience of a CF clinical research center
18. 275 Eating habits and nutritional intervention in CF adolescents
19. 81 Suspected adverse drug reactions (ADRs) caused by intravenous colistin in cystic fibrosis patients may not be dose dependent
20. WS1.2 Rate of decline in serum trypsinogen as a validation for the PIP score
21. Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome
22. 281 Ten years of a prospective haematological survey of patients affected by Shwachman-Diamond syndrome: Results of an Italian multicentric study
23. 194 Phenotypical and functional characterization of mesenchymal stem cells derived from patients affected by Shwachman-Diamond syndrome
24. Hematological and genetic follow-up of 38 italian shwachman-diamond syndrome (SDS) patients
25. 83. Clinical outcome in patients with cystic fibrosis (CF) and either chronic or nonchronic airway colonization by Burkholderia cepacia (Bc)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.